SPP1 and lung carcinoma: Based on in vitro experiments, the inhibition of SPP1 in THP-1 differentiated macrophages co-cultured with the A549 cell line can mitigate lung cancer progression in the cell line model and restore T cell activation (79), showing the potential of targeting SPP1 in various cancers.